After DRL and Spectrum, Cobalt also reached a patent lawsuit settlement with GSK regarding infringement of O.B. listed patents for Sumatriptan Succinate tablets. According to Cobalt it may distribute a generic version in the U.S. by the first quarter of 2009 following the settlement which remains subject to government review.
Read also:
What Glaxo Want?
After DRL, its Spectrum to Settle Imitrex Patent Dispute with Glaxo
No comments:
Post a Comment